✨ Unlock Unlimited Data Exports & Disclosures Access with Tracenable Pro. Learn More →

Vaxcyte Inc

Common Name
Vaxcyte
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
414
Ticker
PCVX
Exchange
NASDAQ/NGS
Description
Vaxcyte Inc. is a biotechnology company focused on developing innovative vaccines for preventing infectious diseases. The primary objective of the company is to create safer and more effective vaccine...

Vaxcyte's Financial Statements Preview

Below are the financial statements of Vaxcyte, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in thousands of USD
2024
2023
2022
Operating expenses
Research and development
-476,644a
-332,341a
-169,451a
Acquired manufacturing rights
0a
-75,000a
-22,995a
General and administrative
-92,902a
-60,700a
-39,810a
Total operating expenses
-569,546a
-468,041a
-232,256a
Loss from operations
-569,546a
-468,041a
-232,256a
Other income (expense), net
Interest expense
0a
0a
-2a
Interest income
109,994a
62,907a
8,356a
Other income (expense)
-4,375a
2,868a
417a
Total other income, net
105,619a
65,775a
8,771a
Net loss
-463,927a
-402,266a
-223,485a
Limited Data Preview
You are viewing a limited preview of Vaxcyte’s income statement data. The reported financial values are complete. The full dataset, available for download, additionally includes structured metadata for each line item, such as line item role (line item, subtotal, total) and financial classification (e.g., assets, liabilities, equity, revenue, expenses).
Unrestricted Access to Data and Sources
pro
Remove manual data sourcing from your workflow. Upgrade to Tracenable Pro for unrestricted access to datasets and disclosures across 8,500+ companies with over 10 years of historical coverage.
Download complete datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace values back to original sources
Formats Included
Excel
CSV
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind Vaxcyte’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Vaxcyte’s data sources below and access millions more through our Disclosure Search.

a. Vaxcyte's 10-K 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?